US Broker Ratings

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unlocking a Potential 52% Upside in Biotech Innovation

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative therapeutic solutions targeting rare kidney and metabolic diseases. With a robust..

Azenta, Inc. (AZTA) Investor Outlook: Positioned for an 84.92% Upside with Promising Analyst Ratings

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector’s medical instruments and supplies industry, offers a unique investment opportunity with a notable potential upside of 84.92%. As the..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Potential 48.91% Upside with Strong Buy Ratings

Investors looking for opportunities in the biotech sector may want to keep a close eye on Apogee Therapeutics, Inc. (NASDAQ: APGE). Based in Waltham, Massachusetts, this clinical-stage biotechnology company is..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a Potential 128.86% Upside in Biotech

Biohaven Ltd. (BHVN), a burgeoning player in the biotechnology sector, is gaining substantial attention from investors due to its ambitious pipeline and significant potential upside. With a market capitalization of..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential Upside of 97% Beckons Investors

Investors with an eye on the biotechnology sector may want to take a closer look at Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the healthcare industry focused on..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 92% Potential Upside in the Biotech Sector

Structure Therapeutics Inc. (GPCR) presents a compelling opportunity for investors in the biotechnology sector, with recent analyst ratings suggesting a substantial potential upside of 92.29%. The company, headquartered in South..

Pediatrix Medical Group (MD) Stock Analysis: Evaluating a 9.46% Potential Upside in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD) stands out in the healthcare sector with its specialized focus on providing neonatal and maternal-fetal medical care. As a key player in the medical..

Dynavax Technologies Corporation (DVAX): Investor Outlook on Potential Upside and Revenue Growth

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a commercial-stage biopharmaceutical company, Dynavax is well-positioned to..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 72.94% Potential Upside Amidst Groundbreaking Gene Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology revolution with its pioneering work in gene editing. This Swiss-based company, operating within the healthcare sector, leverages its..

Omnicell, Inc. (OMCL) Stock Analysis: A 67% Upside Potential Amid Healthcare Technology Innovation

Omnicell, Inc. (OMCL), a prominent player in the healthcare technology sector, is capturing investor attention with its robust growth potential. With a market capitalization of $1.56 billion, Omnicell is well-positioned..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 62.20% Potential Upside

For investors seeking opportunities in the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents a fascinating prospect with its significant potential upside of 62.20%. Specializing in innovative medical devices for the..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Why Analysts Are Bullish with a 37% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is gaining significant attention in the biotechnology sector for its promising pipeline of treatments targeting rare neuromuscular diseases. With a market capitalization of $4.63..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Biotech Powerhouse in Rare Diseases with Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is capturing the attention of the healthcare investment community with its strategic focus on rare diseases. Headquartered in Princeton, New Jersey, this biotechnology firm is..

GeneDx Holdings Corp. (WGS) Investor Outlook: Potential 105.84% Upside Amid Strong Buy Ratings

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector with its innovative approach to genetic testing services. The company, headquartered in Stamford, Connecticut, is at the forefront..

Progyny, Inc. (PGNY) Stock Analysis: A Promising Upside with 60.73% Potential Growth

For investors eyeing innovative healthcare solutions, Progyny, Inc. (NASDAQ: PGNY) presents an intriguing opportunity. Specializing in fertility and family-building benefits management, Progyny has carved out a niche in a burgeoning..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Gem with 17.66% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has emerged as a compelling prospect in the biotech sector, boasting a market capitalization of $4.14 billion. This American biopharmaceutical company, headquartered in Jupiter, Florida,..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Strong Buy Ratings and 50% Upside Potential

For investors seeking opportunities in the biotechnology sector, Kymera Therapeutics, Inc. (NASDAQ: KYMR) offers a compelling prospect. This clinical-stage biopharmaceutical company is making strides with its innovative approach to drug..

IDEAYA Biosciences, Inc. (IDYA) Investor Outlook: Unpacking a 43.72% Potential Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of investors with its promising pipeline in precision medicine oncology. As of its latest trading session, the company’s stock is priced..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook with a Promising 25.80% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the biopharmaceutical sector, is gaining attention for its focus on developing innovative treatments for central nervous system (CNS) diseases. With a..

GoodRx Holdings (GDRX) Stock Analysis: Navigating a 26.82% Potential Upside in the Healthcare Sector

Investors on the lookout for opportunities in the healthcare sector might find GoodRx Holdings, Inc. (NASDAQ: GDRX) an intriguing prospect. As a prominent player in Health Information Services, GoodRx provides..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds